Allspring Global Investments’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

Allspring Global Investments’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-206	Closed	-$5.54K	–	2884
2023 Q1	$5.54K	Buy	206 +103	+100%	+$4.79K	﹤0.01%	2640
2022 Q4	$3.65K	Sell	103 -2	-2%	-$240	﹤0.01%	2808
2022 Q3	$23K	Buy	+105	New	+$25.8K	﹤0.01%	2594
2022 Q2	–	Sell	-406	Closed	-$101K	–	2999
2022 Q1	$101K	Sell	406 -61	-13%	-$9.64K	﹤0.01%	2746
2021 Q4	$72K	Buy	+467	New	+$90.3K	﹤0.01%	2807

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Allspring Global Investments's EIGR Position: Q2 2023 in Review

Allspring Global Investments sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q2 2023, closing a stake of 206 shares — an estimated $5.54K sold.

Allspring Global Investments first reported a position in EIGR in Q4 2021 and held it in 5 quarters. The position peaked at $101K in Q1 2022. 66 funds tracked by Wall St. Rank hold EIGR as of Q2 2023.

Allspring Global Investments reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q2 2023 after selling out during the quarter.
Allspring Global Investments sold 206 Eiger BioPharmaceuticals, Inc. shares in Q2 2023, an estimated $5.54K.
Allspring Global Investments first reported a position in Eiger BioPharmaceuticals, Inc. in Q4 2021 and held it in 5 quarters.
Allspring Global Investments's Eiger BioPharmaceuticals, Inc. position peaked at $101K in Q1 2022.
66 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q2 2023.

Based on Allspring Global Investments's 13F filing for Q2 2023, filed 18 Jul 2023.